Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference108 articles.
1. UNAIDS. Global HIV & AIDS statistics-2019 fact sheet. 2019. http://www.unaids.org/en/resources/fact-sheet. Accessed 19 Aug 2019.
2. European AIDS Clinical Society. European guidelines for treatment of HIV-positive adults in Europe, version 9.1. http://www.eacsociety.org/files/2018_guidelines-9.1-english.pdf. Accessed 14 May 2019.
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. 2018. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed 19 Aug 2019.
4. Orkin C, Squires KE, Molina JM, Sax PE, Wong WW, Sussmann O, et al. Doravirine/lamivudine/tenofovir disoproxil fumarate is non-inferior to efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive adults with human immunodeficiency virus-1 infection: week 48 results of the DRIVE-AHEAD trial. Clin Infect Dis. 2019;68:535–44.
5. Molina JM, Squires K, Sax PE, Cahn P, Lombaard J, DeJesus E, et al. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial. Lancet HIV. 2018;5:e211–20.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献